Cargando…

Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report

BACKGROUND: Osteosarcoma is a highly malignant tumour associated with numerous and complex genetic alterations like copy number alterations. Recent whole genome studies revealed distinct mutations in several candidate oncogenes. While clinical parameters stratify osteosarcoma patients in risk groups...

Descripción completa

Detalles Bibliográficos
Autores principales: Puzik, Alexander, Uhl, Markus, Ruf, Juri, Schumacher, Tilmann, Kontny, Udo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527636/
https://www.ncbi.nlm.nih.gov/pubmed/34670578
http://dx.doi.org/10.1186/s13053-021-00202-0
_version_ 1784586108272640000
author Puzik, Alexander
Uhl, Markus
Ruf, Juri
Schumacher, Tilmann
Kontny, Udo
author_facet Puzik, Alexander
Uhl, Markus
Ruf, Juri
Schumacher, Tilmann
Kontny, Udo
author_sort Puzik, Alexander
collection PubMed
description BACKGROUND: Osteosarcoma is a highly malignant tumour associated with numerous and complex genetic alterations like copy number alterations. Recent whole genome studies revealed distinct mutations in several candidate oncogenes. While clinical parameters stratify osteosarcoma patients in risk groups, genetic profiles have not yet been used to tailor tumour treatment. However, specific copy number alterations seem to have a prognostic impact in osteosarcoma treatment. Somatic TP53 gene mutation frequently occurs in sporadic osteosarcoma. When arising germline, TP53 mutation leads to Li-Fraumeni syndrome and may result in early life osteosarcoma. The effect of Li-Fraumeni syndrome on the genetic profile of osteosarcoma and the consideration of the syndrome during cancer treatment are topics of current research. CASE PRESENTATION: We report a 25-year-old female with pelvic osteosarcoma refusing continuation of therapy. She interrupted neo-adjuvant chemotherapy according to EURAMOS-1/COSS recommendations and declined local or further adjuvant therapy. Surprisingly, she remained in sustained remission for the osteosarcoma but eventually died from newly diagnosed breast cancer. After establishment of breast cancer, we detected TP53 germline mutation and investigated the osteosarcoma material with array-CGH. CONCLUSION: Genetic examination of the tumour evidenced several copy number alterations with striking differences to previously reported data. We discuss possible influences of the genetic profile on the unusual clinical course and the significance of Li-Fraumeni syndrome for the genetic profile. Specific loss of (proto-) oncogenes might have contributed to the unusual case. Further large-scale genetics of Li-Fraumeni patients combined with detailed clinical data will help to identify specific genetic risk profiles and improve treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13053-021-00202-0.
format Online
Article
Text
id pubmed-8527636
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85276362021-10-25 Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report Puzik, Alexander Uhl, Markus Ruf, Juri Schumacher, Tilmann Kontny, Udo Hered Cancer Clin Pract Case Report BACKGROUND: Osteosarcoma is a highly malignant tumour associated with numerous and complex genetic alterations like copy number alterations. Recent whole genome studies revealed distinct mutations in several candidate oncogenes. While clinical parameters stratify osteosarcoma patients in risk groups, genetic profiles have not yet been used to tailor tumour treatment. However, specific copy number alterations seem to have a prognostic impact in osteosarcoma treatment. Somatic TP53 gene mutation frequently occurs in sporadic osteosarcoma. When arising germline, TP53 mutation leads to Li-Fraumeni syndrome and may result in early life osteosarcoma. The effect of Li-Fraumeni syndrome on the genetic profile of osteosarcoma and the consideration of the syndrome during cancer treatment are topics of current research. CASE PRESENTATION: We report a 25-year-old female with pelvic osteosarcoma refusing continuation of therapy. She interrupted neo-adjuvant chemotherapy according to EURAMOS-1/COSS recommendations and declined local or further adjuvant therapy. Surprisingly, she remained in sustained remission for the osteosarcoma but eventually died from newly diagnosed breast cancer. After establishment of breast cancer, we detected TP53 germline mutation and investigated the osteosarcoma material with array-CGH. CONCLUSION: Genetic examination of the tumour evidenced several copy number alterations with striking differences to previously reported data. We discuss possible influences of the genetic profile on the unusual clinical course and the significance of Li-Fraumeni syndrome for the genetic profile. Specific loss of (proto-) oncogenes might have contributed to the unusual case. Further large-scale genetics of Li-Fraumeni patients combined with detailed clinical data will help to identify specific genetic risk profiles and improve treatment. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13053-021-00202-0. BioMed Central 2021-10-20 /pmc/articles/PMC8527636/ /pubmed/34670578 http://dx.doi.org/10.1186/s13053-021-00202-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Puzik, Alexander
Uhl, Markus
Ruf, Juri
Schumacher, Tilmann
Kontny, Udo
Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report
title Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report
title_full Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report
title_fullStr Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report
title_full_unstemmed Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report
title_short Unusual course of disease and genetic profile in Li-Fraumeni syndrome-associated osteosarcoma – a case report
title_sort unusual course of disease and genetic profile in li-fraumeni syndrome-associated osteosarcoma – a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527636/
https://www.ncbi.nlm.nih.gov/pubmed/34670578
http://dx.doi.org/10.1186/s13053-021-00202-0
work_keys_str_mv AT puzikalexander unusualcourseofdiseaseandgeneticprofileinlifraumenisyndromeassociatedosteosarcomaacasereport
AT uhlmarkus unusualcourseofdiseaseandgeneticprofileinlifraumenisyndromeassociatedosteosarcomaacasereport
AT rufjuri unusualcourseofdiseaseandgeneticprofileinlifraumenisyndromeassociatedosteosarcomaacasereport
AT schumachertilmann unusualcourseofdiseaseandgeneticprofileinlifraumenisyndromeassociatedosteosarcomaacasereport
AT kontnyudo unusualcourseofdiseaseandgeneticprofileinlifraumenisyndromeassociatedosteosarcomaacasereport